The Physiological TMPRSS2 Inhibitor HAI-2 Alleviates SARS-CoV-2 Infection

被引:10
|
作者
Tomita, Yuriko [1 ]
Matsuyama, Shutoku [1 ]
Fukuhara, Hideo [2 ,3 ]
Maenaka, Katsumi [2 ,3 ]
Kataoka, Hiroaki [4 ]
Hashiguchi, Takao [5 ]
Takeda, Makoto [1 ]
机构
[1] Natl Inst Infect Dis, Dept Virol 3, Tokyo, Japan
[2] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomol Sci, Sapporo, Hokkaido, Japan
[3] Hokkaido Univ, Fac Pharmaceut Sci, Ctr Res & Educ Drug Discovery, Sapporo, Hokkaido, Japan
[4] Univ Miyazaki, Dept Pathol, Fac Med, Sect Oncopathol & Regenerat Biol, Miyazaki, Japan
[5] Kyoto Univ, Inst Frontier Life & Med Sci, Lab Med Virol, Kyoto, Japan
关键词
SARS-CoV-2; HAI-2; TMPRSS2; ENTRY;
D O I
10.1128/JVI.00434-21
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Hydrogen Sulfide Inhibits TMPRSS2 in Human Airway Epithelial Cells: Implications for SARS-CoV-2 Infection
    Pozzi, Giulia
    Masselli, Elena
    Gobbi, Giuliana
    Mirandola, Prisco
    Taborda-Barata, Luis
    Ampollini, Luca
    Carbognani, Paolo
    Micheloni, Cristina
    Corazza, Francesco
    Galli, Daniela
    Carubbi, Cecilia
    Vitale, Marco
    BIOMEDICINES, 2021, 9 (09)
  • [42] Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
    Meng, Bo
    Abdullahi, Adam
    Ferreira, Isabella A. T. M.
    Goonawardane, Niluka
    Saito, Akatsuki
    Kimura, Izumi
    Yamasoba, Daichi
    Gerber, Pehuen Pereyra
    Fatihi, Saman
    Rathore, Surabhi
    Zepeda, Samantha K.
    Papa, Guido
    Kemp, Steven A.
    Ikeda, Terumasa
    Toyoda, Mako
    Tan, Toong Seng
    Kuramochi, Jin
    Mitsunaga, Shigeki
    Ueno, Takamasa
    Shirakawa, Kotaro
    Takaori-Kondo, Akifumi
    Brevini, Teresa
    Mallery, Donna L.
    Charles, Oscar J.
    Bowen, John E.
    Joshi, Anshu
    Walls, Alexandra C.
    Jackson, Laurelle
    Martin, Darren
    Smith, Kenneth G. C.
    Bradley, John
    Briggs, John A. G.
    Choi, Jinwook
    Madissoon, Elo
    Meyer, Kerstin B.
    Mlcochova, Petra
    Ceron-Gutierrez, Lourdes
    Doffinger, Rainer
    Teichmann, Sarah A.
    Fisher, Andrew J.
    Pizzuto, Matteo S.
    de Marco, Anna
    Corti, Davide
    Hosmillo, Myra
    Lee, Joo Hyeon
    James, Leo C.
    Thukral, Lipi
    Veesler, David
    Sigal, Alex
    Sampaziotis, Fotios
    NATURE, 2022, 603 (7902) : 706 - +
  • [43] Tmprss2 specific miRNAs as promising regulators for SARS-CoV-2 entry checkpoint
    Kaur, Taruneet
    Kapila, Suman
    Kapila, Rajeev
    Kumar, Sandeep
    Upadhyay, Divya
    Kaur, Manjeet
    Sharma, Chandresh
    VIRUS RESEARCH, 2021, 294
  • [44] Prostate cancer and SARS-CoV-2: possible intersections through the TMPRSS2 pathway
    Garcia-Perdomo, Herney Andres
    EUROPEAN JOURNAL OF CANCER PREVENTION, 2021, 30 (06) : 483 - 483
  • [45] Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity
    Bo Meng
    Adam Abdullahi
    Isabella A. T. M. Ferreira
    Niluka Goonawardane
    Akatsuki Saito
    Izumi Kimura
    Daichi Yamasoba
    Pehuén Pereyra Gerber
    Saman Fatihi
    Surabhi Rathore
    Samantha K. Zepeda
    Guido Papa
    Steven A. Kemp
    Terumasa Ikeda
    Mako Toyoda
    Toong Seng Tan
    Jin Kuramochi
    Shigeki Mitsunaga
    Takamasa Ueno
    Kotaro Shirakawa
    Akifumi Takaori-Kondo
    Teresa Brevini
    Donna L. Mallery
    Oscar J. Charles
    John E. Bowen
    Anshu Joshi
    Alexandra C. Walls
    Laurelle Jackson
    Darren Martin
    Kenneth G. C. Smith
    John Bradley
    John A. G. Briggs
    Jinwook Choi
    Elo Madissoon
    Kerstin B. Meyer
    Petra Mlcochova
    Lourdes Ceron-Gutierrez
    Rainer Doffinger
    Sarah A. Teichmann
    Andrew J. Fisher
    Matteo S. Pizzuto
    Anna de Marco
    Davide Corti
    Myra Hosmillo
    Joo Hyeon Lee
    Leo C. James
    Lipi Thukral
    David Veesler
    Alex Sigal
    Fotios Sampaziotis
    Nature, 2022, 603 : 706 - 714
  • [47] Structural analysis of experimental drugs binding to the SARS-CoV-2 target TMPRSS2
    Huggins, David J.
    JOURNAL OF MOLECULAR GRAPHICS & MODELLING, 2020, 100
  • [48] SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
    Hoffmann, Markus
    Kleine-Weber, Hannah
    Schroeder, Simon
    Krueger, Nadine
    Herrler, Tanja
    Erichsen, Sandra
    Schiergens, Tobias S.
    Herrler, Georg
    Wu, Nai-Huei
    Nitsche, Andreas
    Mueller, Marcel A.
    Drosten, Christian
    Poehlmann, Stefan
    CELL, 2020, 181 (02) : 271 - +
  • [49] Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection
    Mura, Manuela
    Bastaroli, Francesca
    Nykjaer, Giulia
    Gnecchi, Massimiliano
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2020, 22 (0N) : N65 - N66
  • [50] Generation of a lethal mouse model expressing human ACE2 and TMPRSS2 for SARS-CoV-2 infection and pathogenesis
    Jeong, Gi Uk
    Hwang, Insu
    Lee, Wooseong
    Choi, Ji Hyun
    Yoon, Gun Young
    Kim, Hae Soo
    Yang, Jeong-Sun
    Kim, Kyung-Chang
    Lee, Joo-Yeon
    Kim, Seong-Jun
    Kwon, Young-Chan
    Kim, Kyun-Do
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2024, 56 (05): : 1221 - 1229